![]() |
|
10 Access |
Related to the teacher |
About
Education
WorkExperience
ResumeTeaching researchSocial PositionReviewer for board of National Natural Science Foundation. Committee Member, the Committee of Pharmacology of Traditional Chinese Medicine & Natural Products, Chinese Pharmacological Society. Committee Member, the Committee of Experimental Pharmacology of Traditional Chinese Medicine, China Association for Traditional Chinese Medicine. Vice Director, Health Care Food Profession Association of Guangdong Province. Council Member, Guangdong Pharmacological Association. Vice Director, the Committee of Pharmacology of Traditional Chinese Medicine, Guangdong Pharmacological Association. Committee Member, World Federation of Chinese Medicine Societies-special committee of medicated diet and diet therapy, World Federation of Chinese Medicine Societies. Research Group Leader of functional food with medicinal and edible materials, World Federation of Chinese Medicine Societies-special committee of medicated diet and diet therapy, World Federation of Chinese Medicine Societies. Vice Director, the Committee of Pharmacy for Elderly, Guangdong Pharmaceutical Association. Committee Member, the Committee of Traditional Chinese Medicine&National Products, Guangdong Pharmaceutical Association. Experts and Technical Experts, Guangdong Medicine Industry Association committee. Experts, Guangdong comprehensive evaluation expert database. Dynamic activityField1. Neuropharmacology Open CourseChinese lecturer of Pharmacology, Pharmacology of Chinese Medicina Materia, Advance Pharmacology, Techniques and Methodologies in Phamarcological Experiences, Treatment and Medication in Regular Disease, Thoughts and Methodologies on Phamarcodynamic Research on Chinese Medicine. English lecturer of Pharmacology, Advanced Pharmacology of Chinese Medicina Materia in Internaltional School of Jinan University. Project1.“Research on the active compounds from Angelica dahurica by Cell membrane chromatography”. Supported by Jinan University Fund for Scholars. 2004.6-2006.6. 2.“Study on the affinity of opiate receptor and different extracts of Angelica dahurica by spermatic duct cell chromatography”. Supported by National Science Foundation. Grant No: 30400596. 2005.1-2007.12. 3.“Establish platelet membrane chromatography model for screening platelet-aggregation- inhibiting active components of Traditional Chinese Medicines.” Supported by Administration of Traditional Chinese Medicine of Guangdong Province. Grant No.2060113. 2006.10-2008.10. 4.“Empirical study of polysaccharides from garlic as a lipotropic agent”. Supported by Administration of Traditional Chinese Medicine of Guangdong Province. Grant No.2007121 2007.10-2009.10. 5.“A pharmacodynamic study of lipotropic agent”. Supported by Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited, 2007.3-2007.12. 6.“A pharmacodynamic study of the anti-osteoporosis capsule”. Supported by Guizhou Tongrentang Pharmaceutical Company Limited, 2008.3-2008.12. 7.“The safety and pharmacodynamic comparative study on the wall-break particle of Dendrobium nobile and its convention cut crude drug”. Supported by Zhongshan Zhongzhi Pharmaceutical Groups, 2009.4-2009.12. 8.“Studytheeffectsofmartineonitchanditsperipheralneuralmechanismsinamodelofcontactdermatitisusingaenhancedgreenfluorescentproteintransgenicmouse”. Supported by Jinan University Fund for Scientific Research and Innovation, 2011.1-2012.1. 9.“The pharmaceutical properties evaluation of the anti-viral integration inhibitor LCVN and it’s derivative”. Supported by National Major Scientific and Technological Special Project for “Significant New Drugs Development”. Grant No:2012ZX09103301-033, 2012.01-2015.12. 10.Protective Effect and Mechanism Research of Compound Danshen Tablet against Myocardial Ischemia/Reperfusion Injury. Supported by Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine Company Limited. 2012.9-2013.12. 11.“Targeting the MrgprA3+ itch-specific neuron to research the anti-pruritic mechanism of components of Radix Sophorae Flavescentis screened by DRG cell membrane chromatography”. Supported by National Science Foundation. Grant No: 81373993, 2014.1-2017.12 . 12.“Protective effects of AGNHW on atherosclerosis rats induced by high fat diet combining cholecalciferol”. Supported by Guangzhou Baiyunshan Zhongyi Chinese Medicine Co. Ltd.2014.1-2016.1. 13.“Research on the secondary development of Shenxiong Glucose Injection”. Supported by Guizhou Jingfeng Injections, Ltd. 2014.2-2016.2. 14.“Experimental Research on selection of protective extract from different Chinese medicine with gastric ulcer model of rat.” In Zhuhai Campus of Zunyi University of Medicine. 2014.3-2014.8. 15.“Pharmacodynamic research on Radix Isatidis Granule” Supported by China Consumer Reports Magazine Ltd. 2015.5-2015.6. 16.“Comparison research on medicine amount changes in rat after single dose administration of different calcium preparations.” Supported by China Consumer Reports Magazine Ltd. 2016.4-2016.10. 17.“Research on the immune mechanism of Angong Niuhuang Pill in the early stage atheroscleroticApoE-/- mice.”Supported by Guangzhou Baiyunshan Zhongyi Chinese Medicine Co. Ltd. 2016.9-2018.9 18.“Pharmacodynamic and mechanism research on Kangfuyan Capsule in a novel added indication.” Supported by Guizhou Yuancheng Pharmaceutical Co., Ltd. 2016.10 -2018.10. 19.“Molecular mechanism research on anti-MIR and anti-arrhythmia effect of Shenxiong Injection based on autophagic signaling pathway.” Supported by National Science Foundation. Grant No: 81673634, 2017.1-2020.12. 20.“Efficacy and safety reconfirm research on the analgesic effect of a compound Miao Ethnomedicine,”. Supported by Chengdu Gaoyang Miao Ethnomedicine Research Co., Ltd. 2017.12-2019.12. 21.“Pharmacodynamic and primary mechanism research on the cardio-gastro-co-treatment effect of Weinaian Capsule.” Supported by Guangzhou Baiyunshan Zhongyi Chinese Medicine Co. Ltd. 2018.4-2019.4. Achievements
The software works
1. Neuropharmacology (1)Application of Loureirin A in the preparation of medicine on prevention and treatment of diabetic angiopathy. Nie, Hong; Tang, Dan; Xiao, Wei; Rao, Jiaoyu; Zhu, Tao. (Jinan University, Peop. Rep. China). Application No.: CN201810825946.X. (2)Application of Kangfuyan preparations in preparation of medicine on treatment of metrosynizesis. Nie, Hong; Ye, Kaihe; Cheng, Jixiang; Xiao, Wei; Chai, Xiaomeng; Fan, Qinghong; Zhu, Tao; Yang, Dan. (Jinan University, Peop. Rep. China). Application No.: CN201710721758.8 (3)A method using Cellular Membrane Immobilized Chromatography on selection of neurological active components of Chinese medicine and its applications. Nie, Hong; Pan, Jianhao; Xu, Xiaoyun; Tang, Dan; Zhang, Zhe. (Jinan University, Peop. Rep. China). Patent. No.: ZL201710347152.2, Authorize bulletin day: 2018.09.06. (4)Application of one Chinese medicine compound in preparation of medicine on treatment of atherosclerosis. Nie, Hong; Lei, Ting; Zhang, Chunbo; Wu, Gang; Fu, Wenjuan; Zhou, Qi; Zhou, Jie; Cheng, Yanyang; Gen, Chunxian; Yin, Zheng. (Jinan University, Peop. Rep. China). Patent. No.: ZL201510100434.3, Authorize bulletin day: 2015.03.06. (5)A cell membrane chromatography used for screening analgesia active ingredients of traditional Chinese medicine. Nie, Hong;Yin Zheng. (Jinan University, Peop. Rep. China). Patent. No.: ZL200810027521, Authorize bulletin day: 2011.11.16. (6)Method for establishing fingerprint chromatogram of ethanol extract of Angelica dahurica .and its application. Nie, Hong; Zhang Hui; Luo, Yong. (Jinan University, Peop. Rep. China). Patent. No.: ZL200610036947.3, Authorize bulletin day: 2011.06.29. (7)Method for establishing fingerprint chromatogram of aqueous extract of Angelica dahurica and its application. Nie, Hong; Zhang, Hui; Luo, Yong. (Jinan University, Peop. Rep. China). Patent. No.: ZL200610036858.9, Authorize bulletin day: 2009.08.12. (8)Method for constructing cell membrane solid-phase chromatography model for screening platelet-aggregation-inhibiting active components of traditional Chinese medicines. Nie, Hong; Meng, Lanzhen; Luo, Yong; Huang, Xuesong. (Jinan University, Peop. Rep. China). Patent. No.: ZL200610122505.0, Authorize bulletin day: 2008.10.29. (9)Application of gingerol oxime in manufacture of platelet aggregation inhibitors. Nie, Hong; Meng, Lanzhen; Feng, Weijing; Huang, Xuesong. (Jinan University, Peop. Rep. China). Patent. No.: ZL200610036605.1, Authorize bulletin day: 2008.06.18. Honor1.“Research on the active compounds from Angelica dahurica by Cell membrane chromatography”. Supported by Jinan University Fund for Scholars. 2004.6-2006.6. 2.“Study on the affinity of opiate receptor and different extracts of Angelica dahurica by spermatic duct cell chromatography”. Supported by National Science Foundation. Grant No: 30400596. 2005.1-2007.12. 3.“Establish platelet membrane chromatography model for screening platelet-aggregation- inhibiting active components of Traditional Chinese Medicines.” Supported by Administration of Traditional Chinese Medicine of Guangdong Province. Grant No.2060113. 2006.10-2008.10. 4.“Empirical study of polysaccharides from garlic as a lipotropic agent”. Supported by Administration of Traditional Chinese Medicine of Guangdong Province. Grant No.2007121 2007.10-2009.10. 5.“A pharmacodynamic study of lipotropic agent”. Supported by Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited, 2007.3-2007.12. 6.“A pharmacodynamic study of the anti-osteoporosis capsule”. Supported by Guizhou Tongrentang Pharmaceutical Company Limited, 2008.3-2008.12. 7.“The safety and pharmacodynamic comparative study on the wall-break particle of Dendrobium nobile and its convention cut crude drug”. Supported by Zhongshan Zhongzhi Pharmaceutical Groups, 2009.4-2009.12. 8.“Studytheeffectsofmartineonitchanditsperipheralneuralmechanismsinamodelofcontactdermatitisusingaenhancedgreenfluorescentproteintransgenicmouse”. Supported by Jinan University Fund for Scientific Research and Innovation, 2011.1-2012.1. 9.“The pharmaceutical properties evaluation of the anti-viral integration inhibitor LCVN and it’s derivative”. Supported by National Major Scientific and Technological Special Project for “Significant New Drugs Development”. Grant No:2012ZX09103301-033, 2012.01-2015.12. 10.Protective Effect and Mechanism Research of Compound Danshen Tablet against Myocardial Ischemia/Reperfusion Injury. Supported by Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine Company Limited. 2012.9-2013.12. 11.“Targeting the MrgprA3+ itch-specific neuron to research the anti-pruritic mechanism of components of Radix Sophorae Flavescentis screened by DRG cell membrane chromatography”. Supported by National Science Foundation. Grant No: 81373993, 2014.1-2017.12 . 12.“Protective effects of AGNHW on atherosclerosis rats induced by high fat diet combining cholecalciferol”. Supported by Guangzhou Baiyunshan Zhongyi Chinese Medicine Co. Ltd.2014.1-2016.1. 13.“Research on the secondary development of Shenxiong Glucose Injection”. Supported by Guizhou Jingfeng Injections, Ltd. 2014.2-2016.2. 14.“Experimental Research on selection of protective extract from different Chinese medicine with gastric ulcer model of rat.” In Zhuhai Campus of Zunyi University of Medicine. 2014.3-2014.8. 15.“Pharmacodynamic research on Radix Isatidis Granule” Supported by China Consumer Reports Magazine Ltd. 2015.5-2015.6. 16.“Comparison research on medicine amount changes in rat after single dose administration of different calcium preparations.” Supported by China Consumer Reports Magazine Ltd. 2016.4-2016.10. 17.“Research on the immune mechanism of Angong Niuhuang Pill in the early stage atheroscleroticApoE-/- mice.”Supported by Guangzhou Baiyunshan Zhongyi Chinese Medicine Co. Ltd. 2016.9-2018.9 18.“Pharmacodynamic and mechanism research on Kangfuyan Capsule in a novel added indication.” Supported by Guizhou Yuancheng Pharmaceutical Co., Ltd. 2016.10 -2018.10. 19.“Molecular mechanism research on anti-MIR and anti-arrhythmia effect of Shenxiong Injection based on autophagic signaling pathway.” Supported by National Science Foundation. Grant No: 81673634, 2017.1-2020.12. 20.“Efficacy and safety reconfirm research on the analgesic effect of a compound Miao Ethnomedicine,”. Supported by Chengdu Gaoyang Miao Ethnomedicine Research Co., Ltd. 2017.12-2019.12. 21.“Pharmacodynamic and primary mechanism research on the cardio-gastro-co-treatment effect of Weinaian Capsule.” Supported by Guangzhou Baiyunshan Zhongyi Chinese Medicine Co. Ltd. 2018.4-2019.4. Enrollment |